The mouse Idd2 locus is linked to the proportion of immunoregulatory double-negative T cells, a trait associated with autoimmune diabetes resistance

Journal of Immunology

Volumn 193, Issue 7, 2014, Pages 3503-3512

  Collin, Roxanne ^a,b   Dugas, Véronique ^a,b   Pelletier, Adam Nicolas ^a,b   Chabot Roy, Geneviève ^a   Lesage, Sylvie ^a,b,c  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; T LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN G; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR DISTRIBUTION; CHROMOSOMAL LOCALIZATION; CHROMOSOME 1; CHROMOSOME 12; CHROMOSOME 2; CHROMOSOME 4; CHROMOSOME 6; CHROMOSOME 9; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; DISEASE RESISTANCE; DOUBLE NEGATIVE T LYMPHOCYTE; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENETIC CORRELATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HOMOZYGOSITY; IDD2 GENE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LINKAGE ANALYSIS; LYMPH NODE; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; RISK REDUCTION; T LYMPHOCYTE; TISSUE DISTRIBUTION; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; GENETICS; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; NONOBESE DIABETIC MOUSE; QUANTITATIVE TRAIT LOCUS;

ANIMALS; DIABETES MELLITUS, TYPE 1; IMMUNOGLOBULIN G; LYMPH NODES; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; QUANTITATIVE TRAIT LOCI; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 84907202713     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400189     Document Type: Article

References (59)

1. Shevach, E. M. 2006. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25: 195-201.
2. Qin, H. Y., R. Mukherjee, E. Lee-Chan, C. Ewen, R. C. Bleackley, and B. Singh. 2006. A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity. Int. Immunol. 18: 1001-1015.
3. Godfrey, D. I., K. J. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today 21: 573-583.
4. Astier, A. L., and D. A. Hafler. 2007. Abnormal Tr1 differentiation in multiple sclerosis. J. Neuroimmunol. 191: 70-78.
5. Hall, A. M., F. J. Ward, M. A. Vickers, L. M. Stott, S. J. Urbaniak, and R. N. B arker. 2002. Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen. Blood 100: 4529-4536.
6. Battaglia, M., A. Stabilini, E. Draghici, B. Migliavacca, S. Gregori, E. Bonifacio, and M. G. Roncarolo. 2006. Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 55: 1571-1580.
7. Singh , R. P., A. La Cava, M. Wong, F. Ebling, and B. H. Hahn. 2007. CD8+ T cellmediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression. J. Immunol. 178: 7649-7657.
8. Filaci, G., S. Bacilieri, M. Fravega, M. Monetti, P. Contini, M. Ghio, M. Setti, F. Puppo, and F. Indiveri. 2001. Impairment of CD8+ T suppressor cell function in patients with act ive systemic lupus erythematosus. J. Immunol. 166: 6452-6457.
9. Zhang, B., X. Zhang, F. Tang, L. Zhu, and Y. Liu. 2008. Reduction of forkhead box P3 levels in CD4+CD25high T cells in patient s with new-onset systemic lupus erythematosus. Clin. Exp. Immunol. 153: 182-187.
10. Long, S. A., K. Cerosaletti, P. L. Bollyky, M. Tatum, H. Shilling, S. Zhang, Z. Y. Zhang, C. Pihoker, S. Sanda, C. Greenbaum, and J. H. Buckner. 2010. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes 59: 407-415.
11. Hillhouse, E. E., J. S. Delisle, and S. Lesage. 2013. Immunoregulatory CD4(-) CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer. Front. Immunol. 4: 6.
12. Chen, W., M. S. Ford, K. J. Young, M. I. Cybulsky, and L. Zhang. 2003. Role of double-negative regulatory T cells in long-term cardiac xenograft survival. J. Immunol. 170: 1846-1853.
13. Chen W.,M.S. Ford,K.J. Young,L. Zhang., 2003, Infusion of in vitrogenerated DN T regulatory cells induces permanent cardiac allograft survival in mice, Transplant. Proc., 35, 2479-2480.
14. Chen, W., D. Zhou, J. R. Torrealba, T. K.Waddell, D. Grant, and L. Zhang. 2005. Donor lymphocyte infusion induces long-term donor-specific cardiac xenograft survival through activation of recipient double-negative regulatory T cells. J. Immunol. 175: 3409-3416.
15. Zhang, Z. X., L. Yang, K. J. Young, B. DuTemple, and L. Zhang. 2000. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat. Med. 6: 782-789.
16. Ford, M. S., K. J. Young, Z. Zhang, P. S. Ohashi, and L. Zhang. 2002. The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J. Exp. Med. 196: 261-267.
17. Young, K. J., L. Yang, M. J. Phillips, and L. Zhang. 2002. Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graftinfiltrating double-negative regulatory T cells. Blood 100: 3408-3414.
18. Young, K. J., B. DuTemple, M. J. Phillips, and L. Zhang. 2003. Inhibition of graft-versus-host disease by double-negative regulatory T cells. J. Immunol. 171: 134-141.
19. He, K. M., Y. Ma, S. Wang, W. P. Min, R. Zhong, A. Jevnikar, and Z. X. Zhang. 2007. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance. Eur. J. Immunol. 37: 3455-3466.
20. McIver, Z., B. Serio, A. Dunbar, C. L. O'Keefe, J. Powers, M. Wlodarski, T. Jin, R. Sobecks, B. Bolwell, and J. P. Maciejewski. 2008. Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation. Br. J. Haematol. 141: 170-178.
21. Ford, M. S., W. Che n, S. Wong, C. Li, R. Vanama, A. R. Elford, S. L. Asa, P. S. Ohashi, and L. Zhang. 2007. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development. Eur. J. Immunol. 37: 2234-2241 .
22. Dugas, V., C. Beauchamp, G. Chabot-Roy, E. E. Hillhouse, and S. Lesage. 2010. Implication of the CD47 pathway in autoimmune diabetes. J. Autoimmun. 35: 23-32.
23. Hillhouse , E. E., C. Beauchamp, G. Chabot-Roy, V. Dugas, and S. Lesage. 2010. Interleukin-10 limits the expansion of immunoregulatory CD4-CD8-T cells in autoimmune-prone non-obese diabetic mice. Immunol. Cell Biol. 88: 771-780.
24. Dugas, V., A. Liston, E. E. Hillhouse, R. Collin, G. Chabot-Roy, A. N. Pelletier, C. Beauchamp, K. Hardy, and S. Lesage. 2014. Idd13 is involved in determining immunoregulatory DN T-cell number in NOD mice. Genes Immun. 15: 82-87.
25. Anderson, M. S., and J. A. Bluestone. 2005. The NOD mouse: a model of imm une dysregulation. Annu. Rev. Immunol. 23: 447-485.
26. Driver, J. P., D. V. Serreze, and Y. G. Chen. 2011. Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Semin. Immunopathol. 33: 67-87.
27. Wicker, L. S., J. A. Todd, and L. B. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13: 179-200.
28. Serreze, D. V., M. Prochazka, P. C. Reifsnyder, M. M. Bridgett, and E. H. Leiter. 1994. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J. Exp. Med. 180: 1553-1558.
29. Allen, P. M., G. R. Matsueda, R. J. Evans, J. B. Dunbar, Jr., G. R. Marshall, and E. R. Unanue. 1987. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature 327: 713-715.
30. Lesage, S., S. B. H artley, S. Akkaraju, J. Wilson, M. Townsend, and C. C. Goodnow. 2002. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J. Exp. Med. 196: 1175-1188.
31. Peterson, D. A., R. J. DiPaolo, O. Kanagawa, and E. R. Unanue. 1999. Quantitative analysis of the T cell repertoire that escapes negative selection. Immunity 11: 453-462.
32. Broman, K. W., H. Wu, S. Sen, and G. A. Churchill. 2003. R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889-890.
33. Haley, C. S., and S. A. Knott. 1992. A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity (Edinb) 69: 315-324.
34. Hillhouse E. E.,R. Collin,G. Chabot-Roy,M. J. Guyon,N. Tessier,M. Boulay,P. Liscourt,S. Lesage., 2013. Nearby construction impedes the progression to overt autoimmune diabetes in NOD mice. J. Diabetes Res. 2013, 620313.
35. Abraham, V. S., D. H. Sachs, and M. Sykes. 1992. Mechanism of protectio n from graft-versus-host disease mortality by IL-2. III. Early reductions in donor T cell subsets and expansion of a CD3+CD4-CD8-cell population. J. Immunol. 148: 3746-3752.
36. Strober, S., S. Dejbachsh-Jones, P. Van Vlasselaer, G. Duwe, S. Salimi, and J. P. Allison. 1989. Cloned natural suppressor cell lines express the CD3+CD4-CD8-surface phenotype and the alpha, beta heterodimer of the T cell antigen receptor. J. Immunol. 143: 1 118-1122.
37. Hillhouse, E. E., and S. Lesage. 2013. A comprehensive review of the phenotype and function of antigen-specific immunoregulatory double negative T cells. J. Autoimmun. 40: 58-65.
38. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15: 535-562.
39. Egawa, T., T. Kr eslavsky, D. R. Littman, and H. von Boehmer. 2008. Lineage diversion of T cell receptor transgenic thymocytes revealed by lineage fate mapping. PLoS ONE 3: e1512.
40. Viret, C., and C. A. Janeway, Jr. 2003. Self-specific MHC class II-restricted CD4-CD8-T cells that escape deletion and lack regulatory activity. J. Immunol. 170: 201-209.
41. Illé s, Z., H. Waldner, J. Reddy, A. C. Anderson, R. A. Sobel, and V. K. Kuchroo. 2007. Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background. Int. Im munol. 19: 1235-1248.
42. Fritsch, M., A. Andersson, K. Petersson, and F. Ivars. 1998. A TCR alpha chain transgene induces maturation of CD4-CD8-alpha beta+ T cells from gamma delta T cell precursors. Eur. J. Immunol. 28: 828-837.
43. Priatel, J. J., O. Utting, and H. S. Teh. 2001. TCR/self-antigen interactions drive double-negative T cell peripheral expansion and differentiation into suppressor cells. J. Immunol. 167: 6188-6194.
44. Liston, A., S. Lesage, D. H. Gray, L. A. O'Reilly, A. Strasser, A. M. Fahrer, R. L. Boyd, J. Wilson, A. G. Baxter, E. M. Gallo, et al. 2004. Generalized re sistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 21: 817-830.
45. Melanitou, E., D. Devendra, E. Liu, D. Miao, and G. S. Eisenbarth. 2004. Early and quantal (by litter) expression of insulin autoantibodies in the nonobese diabetic mice predict early diabetes onset. J. Immunol. 173: 6603-6610.
46. Yu, L., D. T. Robles, N. Abiru, P. Kaur, M. Rewers, K. Kelemen, and G. S. Eisenbarth. 2000. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc. Natl. Acad. Sci. USA 97: 1701-1706.
47. Silva, D. G., S. R. Daley, J. Hogan, S. K. Lee, C. E. Teh, D. Y. Hu, K. P. Lam, C. C. Goodnow, and C. G.Vinuesa. 201 1. Anti-islet autoantibodies trigger autoimmune diabetes in the presence of an increased frequency of islet-reactive CD4 T cells. Diabetes 60: 2102-2111.
48. McAleer, M. A., P. Reifsnyder, S. M. Palmer, M . Prochazka, J. M. Love, J. B. Copeman, E. E. Powell, N. R. Rodrigues, J. B. Prins, D. V. Serreze, et al. 1995. Crosses of NOD mice with the related NON strain. A polygenic model for IDDM. Diabetes 44: 1186-1195.
49. Prochazka, M., E. H. Leiter, D. V. Serreze, and D. L. Coleman. 1987. Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice. Science 237: 286-289.
50. Pearce, R. B., B. Formby, K. Healy, and C. M. Peterson. 1995. Association of an androgen-responsive T cell phenotype with murine diabetes and Idd2. Autoimmunity 20: 247-258.
51. Pearce, R. B. 1998. Fine-mapping of the mouse T lymphocyte fraction (Tlf) locus on chromosome 9: association with autoimmune diabetes. Autoimmunity 28: 31-45.
52. Prochazka, M., D. V. Serreze, S. M. Worthen, and E. H. Leiter. 1989. Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks. Diabetes 38: 1446-1455.
53. Rudd, C. E., and H. Schneider. 2000 . Lymphocyte signaling: Cbl sets the threshold for autoimmunity. Curr. Biol. 10: R344-R347.
54. Manjarrez-Ordun? o, N., E. Marasco, S. A. Chung, M. S. Katz, J. F. Kiridly, K. R. Simpfendorfer, J. Freudenberg, D. H. Ballard, E. Nashi, T. J. Hopkins, et al. 2012. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat. Genet. 44: 1227-1230.
55. Martin, J. E., J. C. Broen, F. D. Carmona, M. Teruel, C. P. Simeon, M. C. Vonk, R. van 't Slot, L. Rodriguez-Rodriguez, E. Vicente, V. Fonollosa, et al; Spanish Scleroderma Group. 2012. Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up. Hum. Mol. Genet. 21: 2825-2835.
56. Novick, D., S. Kim, G. Kaplanski, and C. A. Dinarello. 2013. Interleukin-18, more than a Th1 cytokine. Semin. Immunol. 25: 439-448.
57. Takeuchi, A., Y. Itoh, A. Takumi, C. Ishihara, N. Arase, T. Yokosuka, H. Koseki, S. Yamasaki, Y. Takai, J.Miyoshi, et al. 2009. CRTAMconfers late-stage activation of CD8+ T cells to regulate retention within lymph node. J. Immunol. 183: 4220-4228.
58. Sudo, T., T. Yokota, K. Oritani, Y. Satoh, T. Sugiyama, T. Ishida, H. Shibayama, S. Ezoe, N. Fujita, H. Tanaka, et al. 2012. The endothelial antigen ESAM monitors hematopo ietic stem cell status between quiescence and self-renewal. J. Immunol. 189: 200-210.
59. Smink, L. J., E. M. Helton, B. C. Healy, C. C. Cavnor, A. C. Lam, D. Flamez, O. S. Burren, Y. Wang, G. E. Dolman, D. B. Burdick, et al. 2005. T1DBase, a community web-based resource for type 1 diabetes research. Nucleic Acids Res. 33: D544-D549